Ixazomib, ONC201, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT03492138 · TERMINATED
Trial details
- NCT number
- NCT03492138
- Sponsor
- Ajai Chari
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-26
- Primary completion
- 2020-01-14
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.